Solesence, Inc
Solésence, Inc. develops and manufactures skin-health products and ingredients for beauty and life-science applications, including consumer products, active pharmaceutical ingredients, and legacy advanced materials. The company operates through its Solésence consumer products subsidiary and maintains development, application, and manufacturing capabilities in the Chicago, Illinois area.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaFinished skin-care, sun-care, and color cosmetics sold through brand partners to end consumers.
Active ingredients and related materials used in skin-health and sunscreen formulations.
Legacy engineered materials and specialty applications outside the core skin-health focus.
Tuotteet
Raportoitu · osuus liikevaihdosta- Consumer Products88,0 %
- Personal Care Ingredients10,2 %
- Advanced Materials1,4 %
- Other0,4 %
Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.
Asiakkaat
Solésence sells primarily to brand partners that bring finished beauty and skin-health products to market, rather than directly to consumers. Its customer base also includes a smaller set of ingredient buyers that use APIs and engineered materials in sunscreen and personal-care formulations. Revenue is concentrated in a few large customers, which makes customer retention and new account wins especially important.
Buy finished skin-care, sun-care, and color cosmetics products for resale under their own labels.
Buy APIs and engineered materials for use in sunscreen and skin-health formulations.
Use Solésence technologies for premium positioning and differentiated product performance.
Use the platform for broader distribution and consumer-facing skin-health products.
Strategia
Solésence is prioritizing its consumer-products platform as the main growth engine while continuing to serve ingredient and legacy advanced-materials customers. The strategy centers on using proprietary materials science and formulation capabilities to create differentiated products that brands can commercialize across prestige and mass beauty channels.
Consumer products are the core growth vector and can leverage the company’s formulation and manufacturing platform.
Differentiated materials and nano/non-nano coating know-how support product performance and customer stickiness.
Revenue concentration increases dependence on individual customer decisions and order timing.
Maantiede
Q1/2026Solésence is a U.S.-based company with development, application, and manufacturing operations in the Chicago, Illinois area. The available disclosures do not provide a country-by-country revenue split, so the business profile is best understood as domestically operated with potential customer exposure through brand partners rather than direct international reporting. Its operating footprint matters because formulation, manufacturing, and packaging are all performed close to its technical and production base.
Riskit
Solésence faces customer concentration risk, since a large share of revenue comes from a small number of accounts and order timing can move quarterly results. It also faces execution and input-cost risk tied to manufacturing, pricing, and the ability to pass through inflation, while its niche beauty and ingredient markets remain competitive and formulation-driven.
A small number of customers account for a large portion of revenue, so losing or delaying one account would materially affect sales.
Kohdistuu: Consumer products and personal care ingredients
Supplier price increases and wage inflation can compress economics if pricing cannot be passed through.
Kohdistuu: Manufacturing and packaging operations
Growth depends on converting proprietary technology into repeatable customer programs and new product launches.
Kohdistuu: Brand-partner product development
Customer purchase timing can shift revenue between periods, making results uneven and harder to forecast.
Kohdistuu: Consumer products and APIs
Kirjanpito
Harkinnanvaraiset erätSales include consumer products, APIs, and customer development arrangements, so timing can differ by contract type and delivery milestone.
Vaikutus: Affects quarterly revenue comparability and gross profit timing
Concentration in a few customers increases the importance of receivable collectability estimates.
Vaikutus: Can affect SG&A and reported earnings
Large tax loss carryforwards may be limited by ownership-change rules and expiration dates.
Vaikutus: Affects future tax benefit realization
Legacy advanced materials activities may require impairment review if cash generation weakens.
Vaikutus: Could affect operating results and balance-sheet carrying values
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Bio Essence Corp
BIOE · Pharmaceutical Preparations
Bio Essence Corp is a California-based holding company whose operating history has centered on health supplements and OEM manufacturing/distribution services.
Solstice Advanced Materials Inc.
SOLS · Chemicals & Allied Products
Sunhydrogen, Inc.
HYSR · Semiconductors & Related Devices
Nature's Sunshine Products, Inc
NATR · Pharmaceutical Preparations
Nature’s Sunshine Products is a U.S.-based natural health and wellness company that manufactures and sells nutritional supplements and personal care products.
Solana Co
HSDT · Finance Services
Solana Co is a U.S.-based public company organized around a Solana digital asset treasury strategy, with Solana (SOL) as its primary treasury reserve asset.
Soligenix, Inc
SNGX · Pharmaceutical Preparations
Päivitetty: 24.9.2026